Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

536279

registered interest
date	13/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of (a) the effect of the National Tariff on the choice of antibiotic therapy available in hospitals and (b) the implications of the cost of such therapy for that availability.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	42714
answer	answer is ministerial correction date of answer 20/07/2016 answer text <p>The Health and Social Care Act 2012 Act transferred responsibility for developing payment systems for health care services from the Department to NHS England and NHS Improvement (formerly Monitor). The costs of drugs that are used in the course of a patient’s stay in hospital are reimbursed via the Healthcare Resource Group tariff that the provider receives for that spell.</p><p> </p><p>We are advised by NHS England that they are not aware of issues with the national tariff having an impact on the choice of antibiotic therapy available in hospitals.</p><p><strong> </strong></p><p>The decision on whether to prescribe an antibiotic is entirely a matter for the clinician, based on his or her clinical judgement.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 20/07/2016 14:21:20 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4474 label Biography information for Kevin Hollinrake

528073

registered interest
date	20/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, by what process his Department plans to evaluate and continue to develop national antibiotic prescribing targets for primary and secondary care.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	41033
answer	answer is ministerial correction date of answer 04/07/2016 answer text <p>The Department takes advice on the measurement of prescribing levels and the development of objectives for levels of prescribing of antibiotics from the Department’s Health’s Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections as well as the English Surveillance Programme for Antimicrobial Utilisation and Resistance.</p><p> </p><p>The English Surveillance Programme on Antimicrobial Use and Resistance, (ESPAUR), was established by Public Health England (PHE) in 2013 in response to the publication of the UK 5 year Strategy on Antimicrobial Resistance (AMR). ESPAUR provides the data on prescribing of antibiotics and levels of resistance to antibiotics in both primary and secondary care that allows the Department to evaluate progress.</p><p> </p><p>PHE uses the ESPAUR data to provide ongoing expert advice to NHS England to enable ongoing development of commissioning incentives to encourage healthcare providers to achieve the antibiotic prescribing quality measures recommended by the national expert Advisory Group on AMR and Healthcare Associated Infections for primary and secondary care.</p><p> </p><p>The Department’s Policy Research Programme has also commissioned the Imperial National Institute for Health Research Health Protection Research Unit to evaluate and research the impact of reduced antibiotic prescribing on hospital admissions and mortality.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/07/2016 14:20:19 answering member 3918 label Biography information for Jane Ellison
tabling member	4474 label Biography information for Kevin Hollinrake

514779

registered interest
date	21/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department plans to reform the reimbursement of antibiotics.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	35027
answer	answer is ministerial correction date of answer 29/04/2016 answer text <p>Departmental officials are in discussion with the Association of the British Pharmaceutical Industry regarding pricing and reimbursement models for antibiotics.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/04/2016 12:40:37 answering member 3918 label Biography information for Jane Ellison
tabling member	4474 label Biography information for Kevin Hollinrake

514782

registered interest
date	21/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department has had discussions with officials in HM Treasury on reforming the reimbursement of antibiotics.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	35012
answer	answer is ministerial correction date of answer 29/04/2016 answer text <p>Departmental officials are in discussion with the Association of the British Pharmaceutical Industry regarding pricing and reimbursement models for antibiotics. HM Treasury are aware of these discussions.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/04/2016 12:47:10 answering member 3918 label Biography information for Jane Ellison
tabling member	4474 label Biography information for Kevin Hollinrake